Leila Amini

1.5k citations
22 papers · 790 indexed · 2 hit papers · h-index 12

Leila Amini

22 papers receiving 774 citations

Hit Papers

High prevalence of Streptococcus pyogenes Cas9-reactive T...20182026202020232018202250100150200250

Peers

Leila Amini
Comparison fields: 5 of 80
  • Molecular Biology 431
  • Oncology 341
  • Genetics 180
  • Immunology 153
  • Biomedical Engineering 126
Replace Eman A. Taha with:
Eman A. Taha Japan
Rui Tian China
Da Zhu China
Ming-Hui Fan United States
Tatiana Flisikowska Germany
Yuexin Zhou China
Αndroulla N. Miliotou Greece
Julian Boutin France
Lisa Zhao United States
Sisi He China
Leila Amini relative to Eman A. Taha Japan Eman A. Taha's profile →
Citations per field
00.5×10×20×30×40×50×
Eman A. Taha · 1×
Citations per year

Countries citing papers authored by Leila Amini

Since Specialization
Citations

This map shows the geographic impact of Leila Amini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leila Amini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leila Amini more than expected).

Fields of papers citing papers by Leila Amini

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Leila Amini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leila Amini. The network helps show where Leila Amini may publish in the future.

Co-authorship network of co-authors of Leila Amini

This figure shows the co-authorship network connecting the top 25 collaborators of Leila Amini. A scholar is included among the top collaborators of Leila Amini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Leila Amini. Leila Amini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 5
3 22
4 29
5 3
6
Preparing for CAR T cell therapy: patient selection, bridging therapies and lymphodepletionbreakdown →
204
7 9
8 38
9 26
10 14
11 37
12 5
13 9
14 3
15
High prevalence of Streptococcus pyogenes Cas9-reactive T cells within the adult human populationbreakdown →
293
16 17
17 13
18 16
19 40
20
STERILIZATION OF ESHERICHIA COLI AND THE MICROORGANISMS OF TURMERIC SAMPLES WITH CORONA DISCHARGE PLASMA
1

About Leila Amini

Leila Amini is a scholar working on Oncology, Immunology and Hepatology, having authored 22 papers that have together received 790 indexed citations. Recurring topics across this work include CAR-T cell therapy research (8 papers), Immune Cell Function and Interaction (5 papers) and CRISPR and Genetic Engineering (4 papers). The work is most often cited by research in Business and International Management (33 citations), Oncology (341 citations) and Immunology (153 citations). Leila Amini has collaborated with scholars based in Germany, United States and Belgium. Frequent co-authors include Petra Reinke, Michael Schmueck‐Henneresse, Hans‐Dieter Volk, Dimitrios L. Wagner, Désirée J. Wendering, Levent Akyüz, Shannon L. Maude, Carlos A. Ramos, Sara Silbert and Renier J. Brentjens. Their work appears in journals such as Nature Medicine, Scientific Reports and International Journal of Molecular Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026